These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Price type key:
Federal Supply Schedule (FSS): generally available to all Federal Govt agencies /
'BIG4' prices: VA, DoD, Public Health & Coast Guard only /
National Contracts (NC): Available to specific agencies
70000-0161 Market Analysis and Financial Projection
Market Analysis and Price Projections for the Drug NDC: 70000-0161
Understanding the National Drug Code (NDC)
Before diving into the market analysis and price projections for the drug with the NDC 70000-0161, it is crucial to understand what an NDC is and its significance in the healthcare industry.
Definition and Purpose: The National Drug Code (NDC) is a unique 11-digit code assigned to each medication by the FDA. It is used to identify the labeler (manufacturer), product (drug), and packaging (configuration and quantity)[1].
Drug Identification and NDC 70000-0161
Drug Identification: The NDC 70000-0161 is associated with a specific drug product. However, the exact drug name and details are not provided in the sources. To analyze this drug, one would typically look up the NDC in databases such as those provided by First DataBank or AnalySource[2].
Market Dynamics and Price Trends
General Price Trends in Pharmaceuticals
Price Increases: The pharmaceutical industry has seen significant price increases over the years. For instance, between 2018 and 2023, many drugs experienced list price increases ranging from 20% to 55%[2].
Extraordinary Price Rises: Some drugs, particularly those targeting small patient populations or with limited distribution channels, have seen extraordinary price increases, sometimes exceeding 1,000%[3].
Impact of Medicare Drug Price Negotiation
Negotiated Prices: Starting in 2026, Medicare will implement negotiated prices for certain drugs, which are expected to reduce costs significantly. For the first cycle of negotiations, the negotiated prices resulted in discounts ranging from 38% to 79% compared to list prices[2][5].
Savings Projections: The implementation of these negotiated prices is projected to save Medicare an estimated $6 billion in net covered prescription drug costs in 2023 if applied retroactively, and $1.5 billion for people with Medicare Part D coverage in 2026[5].
Price Projections for NDC 70000-0161
Current Pricing Data
Wholesale Prices: For drugs like the one with NDC 70000-0046 (though not the exact NDC in question), wholesale prices can be tracked over time. For example, the wholesale price for NDC 70000-0046 has fluctuated slightly over recent months, indicating stable pricing trends for certain drugs[4].
Potential Price Movements
Regulatory Impact: If the drug associated with NDC 70000-0161 is selected for future Medicare price negotiations, it could see significant price reductions similar to those observed in the first cycle of negotiations.
Market Conditions: Factors such as intellectual property status, distribution channels, and demand can influence price movements. Drugs with limited competition or unique market positions may see higher price stability or increases[3].
Data Sources and Analysis
AnalySource and First DataBank: These databases provide detailed pricing information at the NDC level, allowing for the aggregation of prices and analysis of market trends. They are crucial for understanding the pricing dynamics of specific drugs[2].
Key Considerations for Price Projections
List Price vs. Negotiated Price: The difference between list prices and negotiated prices can be substantial. For accurate projections, it is essential to consider whether the drug will be subject to negotiated prices under programs like Medicare Part D[2][5].
Volume and Distribution: The volume of sales and distribution channels can affect pricing. Drugs dispensed primarily through mail-order pharmacies or those with limited retail presence may have different pricing dynamics[2].
Conclusion
The market analysis and price projections for the drug with NDC 70000-0161 depend on several factors, including regulatory changes, market conditions, and the drug's specific characteristics. Here are some key points to consider:
Regulatory Changes: Future price negotiations under Medicare Part D could significantly impact the drug's pricing.
Market Trends: General trends in pharmaceutical pricing, including extraordinary price rises for certain drugs, need to be considered.
Data Sources: Utilizing databases like AnalySource and First DataBank is crucial for accurate pricing data and trend analysis.
Key Takeaways
NDC Significance: The NDC is a critical identifier in the healthcare industry, used for tracking, billing, and safety purposes.
Price Trends: Pharmaceutical prices have seen significant increases, but regulatory changes like Medicare negotiations can lead to substantial discounts.
Data Analysis: Accurate price projections require detailed data from reliable sources and consideration of market and regulatory factors.
FAQs
What is the National Drug Code (NDC)?
The NDC is a unique 11-digit code assigned by the FDA to identify each medication, including the labeler, product, and packaging[1].
How do Medicare negotiations affect drug prices?
Medicare negotiations can result in significant discounts, ranging from 38% to 79% compared to list prices, as seen in the first cycle of negotiations[2][5].
What factors influence pharmaceutical price trends?
Factors include intellectual property status, distribution channels, demand, and regulatory changes such as Medicare price negotiations[3].
Where can I find detailed pricing data for a specific NDC?
Detailed pricing data can be found in databases such as AnalySource and First DataBank, which provide list prices and market trends at the NDC level[2].
How do wholesale prices reflect market trends?
Wholesale prices can indicate stability or fluctuations in market trends over time, providing insights into the drug's pricing dynamics[4].
Sources
FDA Drug Topics Webinar - National Drug Code (NDC) for Healthcare Providers.
ASPE - HHS.gov - Medicare Drug Price Negotiation Program.
S&P Global Market Intelligence - New Study Indicates "Extraordinary" Price Rises in 17 Drugs in U.S.
DrugPatentWatch - Latest pharmaceutical drug prices and trends for NDC 70000-0046.
CMS.gov - Negotiated Prices for Initial Price Applicability Year 2026.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.